Nectar
New York
About Nectar
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research. The company was founded in 2021 and is headquartered in New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $24.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: mynectar.com
Industries & Categories
Clinical Trials, Health Care, Health Diagnostics, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nectar-93461 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.